Strong Top-Line Growth
Total revenue grew 10.2% year-over-year with organic growth of 6.6%. The company exited March with approximately 12% total growth and over 8% organic growth, and organic growth improved ~90 basis points versus Q4 2025.
Broad-Based Segment Strength
Residential revenue increased 9.3% (organic ~4.2%), commercial pest control rose 9.6% (organic 7.7%), and termite & ancillary grew 13.5% (organic ~10%).
Profitability and Margin Metrics
GAAP operating income was $145M (up 2% YoY). Adjusted operating income was $153M (up 4% YoY). Adjusted EBITDA was $179M (up 4.4% YoY) representing a 19.8% margin.
Earnings Per Share and Adjusted Net Income
GAAP net income was $108M or $0.22 per share. Adjusted net income (after ~$7M pretax adjustments) was $113M or $0.24 per share, up 9.1% year-over-year.
Strong Cash Generation and Balance Sheet
Operating cash flow was $118M and free cash flow was $111M. Free cash flow conversion exceeded 100% for the quarter (would have been ~140% excluding timing/one-time items). Leverage ratio stood at 0.9x and the balance sheet described as very healthy.
Disciplined Capital Allocation
Q1 acquisitions totaled $18M; dividends paid were $88M. Management expects M&A to contribute 2%–3% to revenue growth in 2026 and reiterated a balanced capital allocation strategy.
Pricing and Tax Improvements
Recent price increases are expected to contribute 3%–4% of growth for the year (ahead of CPI). Effective tax rate improved to 21.3% (versus 23.5%) and management expects a rate under 25% for the year, roughly 100 basis points below historical levels.
Confident 2026 Outlook
Management reiterated guidance of 7%–8% organic growth for 2026 plus 2%–3% from M&A, confidence in improving incremental margin profile through peak season, and expectation of cash flow conversion above 100% for the year.